176
RxSight, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
Assets
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
135
FY23:
168
FY24:
294
FY25:
287
(positive)
Change from FY21 to FY25
millions USD
FY21:
16.4
FY22:
15.6
FY23:
14.1
FY24:
24.7
FY25:
24.4
Total assets
Change from FY21 to FY25
millions USD
FY21:
193
FY22:
150
FY23:
183
FY24:
319
FY25:
312
Liabilities & Equity
(negative)
Change from FY21 to FY25
millions USD
FY21:
11.1
FY22:
17.2
FY23:
20.9
FY24:
25.9
FY25:
26.3
(negative)
Change from FY21 to FY25
millions USD
FY21:
43.4
FY22:
43.0
FY23:
1.29
FY24:
11.4
FY25:
9.88
(positive)
Change from FY21 to FY25
millions USD
FY21:
138
FY22:
89.9
FY23:
160
FY24:
281
FY25:
276
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
193
FY22:
150
FY23:
183
FY24:
319
FY25:
312
All amounts in millions USD